Arkolith/Insider Trading/FBRX/Form 4

Wagner Paul A.

See Remarks, DirectorForte Biosciences, Inc. (FBRX) · full profile →Form 4 · filed Dec 15, 2023
Net Buying
Open-Market Buys
$15K
Open-Market Sells
$0
Net Open-Market Flow
$15K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 14, 2023Buy(P)10K$0.72$7K1.8M
Dec 13, 2023Buy(P)11K$0.70$7K1.8M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-058867) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML